Description

Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses.

Figure 14

Chart

Source Paper

Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled …

Nutrients (2020)

PMID: 32326347

DOI: 10.3390/nu12041159

Cite This Figure

![Figure 14: Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses.]()

> Source: Erin D Lewis et al. "Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in A." *Nutrients*, 2020. PMID: [32326347](https://pubmed.ncbi.nlm.nih.gov/32326347/)

<figure>
  <img src="" alt="Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses." />
  <figcaption>Figure 14. Supplementary data from the probiotic IBS trial, providing additional microbiome or clinical outcome analyses.<br>  Source: Erin D Lewis et al. "Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in A." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32326347/">32326347</a></figcaption>
</figure>

Related Evidence

Bifidobacterium longum for Irritable Bowel Syndrome (IBS)

Grade B · 4 studies